City: 69120 Heidelberg
Im Neuenheimer Feld 267
We are building digital pathology application for biomarker analysis in epidemiological and clinical studies.
This includes management and supporting the creation of very large data collections from whole-slide imaging.
In large epidemiological studies AI image analysis is validated yielding clinically useful biomarker analysis for translating research projects into applications.
This generic project is intended to be a forum for all LiSyM partner and external stakeholders interested in participating in the BMBF initiative LiSyM-Krebs.
Organisms: Not specified
In chronic diseases, at some point the liver can suddenly stop functioning. This is called acute-on-chronic liver failure, or ACLF. This is the leading cause of death in liver patients and is often provoked by the use of transcription or freely available drugs or alcohol abuse. For this condition we need an effective treatment quickly.
LiSyM-Pillar III researches the factors that contribute significantly to ACLF. What exactly happens then? Are there any early signs that would enable ACLF to be